Literature DB >> 35439030

Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers?

Maha Hussain1, Michael A Carducci2, Noel Clarke3, Sarah E Fenton1, Karim Fizazi4, Silke Gillessen5,6,7, Heather Jacene8, Michael J Morris9, Fred Saad10, Oliver Sartor11, Mary-Ellen Taplin12, Neha Vapiwala13, Scott Williams14, Christopher Sweeney12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35439030     DOI： 10.1200/JCO.22.00208

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   50.717


× No keyword cloud information.
  2 in total

1.  Future directions in systemic treatment of metastatic hormone-sensitive prostate cancer.

Authors:  Kenneth Chen; Louise Kostos; Arun A Azad
Journal:  World J Urol       Date:  2022-08-27       Impact factor: 3.661

2.  Rates of Positive Abdominal Computed Tomography and Bone Scan Findings Among Men with Cambridge Prognostic Group 4 or 5 prostate cancer: A Nationwide Registry Study.

Authors:  Caroline Stenman; Emelie Abrahamsson; Mikael Redsäter; Vincent J Gnanapragasam; Ola Bratt
Journal:  Eur Urol Open Sci       Date:  2022-06-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.